TrialAdvances in therapy2025

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.

Mark G Lebwohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.